Phibro Animal Health Corporation (PAHC)

Phibro Animal Health Income Statement

Financials in millions USD. Fiscal year is July - June.

Year	2023	2022	2021	2020	2019
Revenue	977.89	942.26	833.35	800.35	828
Revenue Growth (YoY)	3.78%	13.07%	4.12%	-3.34%	0.98%
Cost of Revenue	679.65	656.86	561.97	543.47	563.37
Gross Profit	298.24	285.4	271.38	256.88	264.62
Selling, General & Admin	226.39	206.41	196.51	187.69	181.4
Operating Expenses	226.39	206.41	196.51	187.69	181.4
Operating Income	71.85	78.99	74.87	69.19	83.23
Interest Expense / Income	15.32	11.88	12.88	12.86	11.78
Other Expense / Income	2.46	-5.22	-4.48	0.83	-0.06
Pretax Income	54.07	72.33	66.47	55.51	71.51
Income Tax	21.47	23.15	12.08	21.96	16.79
Net Income	32.61	49.18	54.39	33.55	54.71
Net Income Growth	-33.69%	-9.58%	62.09%	-38.68%	-15.67%
Shares Outstanding (Basic)	41	41	40	40	40
Shares Outstanding (Diluted)	41	41	41	41	41
Shares Change	-	-	-	-0.05%	0.34%
EPS (Basic)	0.81	1.21	1.34	0.83	1.35
EPS (Diluted)	0.81	1.21	1.34	0.83	1.35
EPS Growth	-33.06%	-9.70%	61.45%	-38.52%	-16.15%
Free Cash Flow	-38.48	-5.4	18.99	25.3	17.28
Free Cash Flow Per Share	-0.95	-0.13	0.47	0.63	0.43
Dividend Per Share	0.480	0.480	0.480	0.480	0.460
Dividend Growth	0%	0%	0%	4.35%	15.00%
Gross Margin	30.50%	30.29%	32.56%	32.10%	31.96%
Operating Margin	7.35%	8.38%	8.98%	8.65%	10.05%
Profit Margin	3.33%	5.22%	6.53%	4.19%	6.61%
Free Cash Flow Margin	-3.94%	-0.57%	2.28%	3.16%	2.09%
Effective Tax Rate	39.70%	32.01%	18.18%	39.56%	23.48%
EBITDA	103.4	116.91	111.23	100.71	110.85
EBITDA Margin	10.57%	12.41%	13.35%	12.58%	13.39%
Depreciation & Amortization	34.01	32.71	31.89	32.34	27.56
EBIT	69.39	84.2	79.35	68.37	83.28
EBIT Margin	7.10%	8.94%	9.52%	8.54%	10.06%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).